Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Dysraphism | 35 | 2025 | 270 | 8.830 |
Why?
|
| Meningomyelocele | 20 | 2025 | 250 | 3.220 |
Why?
|
| Neural Tube Defects | 8 | 2024 | 356 | 2.020 |
Why?
|
| Emigrants and Immigrants | 3 | 2023 | 144 | 1.930 |
Why?
|
| Fetoscopy | 11 | 2025 | 447 | 1.260 |
Why?
|
| Global Health | 7 | 2025 | 574 | 1.100 |
Why?
|
| Fecal Incontinence | 6 | 2024 | 72 | 1.040 |
Why?
|
| Neurosurgery | 4 | 2024 | 75 | 1.020 |
Why?
|
| Hydrocephalus | 7 | 2025 | 244 | 0.990 |
Why?
|
| Social Determinants of Health | 3 | 2024 | 127 | 0.920 |
Why?
|
| Autistic Disorder | 3 | 2022 | 351 | 0.880 |
Why?
|
| Urinary Bladder, Neurogenic | 3 | 2022 | 45 | 0.880 |
Why?
|
| Self-Management | 3 | 2022 | 99 | 0.850 |
Why?
|
| Intermittent Urethral Catheterization | 2 | 2022 | 8 | 0.780 |
Why?
|
| Hysterotomy | 7 | 2025 | 126 | 0.760 |
Why?
|
| Urinary Incontinence | 4 | 2024 | 71 | 0.700 |
Why?
|
| Transition to Adult Care | 5 | 2024 | 118 | 0.690 |
Why?
|
| Registries | 8 | 2024 | 1454 | 0.600 |
Why?
|
| Language | 1 | 2019 | 199 | 0.550 |
Why?
|
| Telemedicine | 1 | 2023 | 448 | 0.530 |
Why?
|
| Autism Spectrum Disorder | 1 | 2022 | 395 | 0.520 |
Why?
|
| Humans | 66 | 2025 | 126330 | 0.490 |
Why?
|
| Mothers | 1 | 2019 | 357 | 0.490 |
Why?
|
| Child | 29 | 2025 | 24766 | 0.490 |
Why?
|
| Prenatal Care | 3 | 2023 | 349 | 0.470 |
Why?
|
| Quality of Life | 5 | 2022 | 1954 | 0.470 |
Why?
|
| Down Syndrome | 3 | 2020 | 203 | 0.450 |
Why?
|
| Pregnancy | 15 | 2025 | 7257 | 0.440 |
Why?
|
| Fetal Diseases | 3 | 2025 | 458 | 0.430 |
Why?
|
| Adolescent | 27 | 2025 | 19548 | 0.430 |
Why?
|
| Young Adult | 20 | 2024 | 9174 | 0.420 |
Why?
|
| Neurosurgical Procedures | 4 | 2024 | 303 | 0.420 |
Why?
|
| Child, Preschool | 22 | 2025 | 14221 | 0.410 |
Why?
|
| Female | 39 | 2025 | 67333 | 0.400 |
Why?
|
| International Educational Exchange | 1 | 2012 | 16 | 0.380 |
Why?
|
| Walking | 2 | 2024 | 218 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 3 | 2025 | 1274 | 0.340 |
Why?
|
| Scoliosis | 2 | 2022 | 135 | 0.340 |
Why?
|
| Longevity | 2 | 2023 | 150 | 0.330 |
Why?
|
| Urinary Bladder Diseases | 2 | 2021 | 33 | 0.320 |
Why?
|
| Motor Activity | 3 | 2021 | 527 | 0.320 |
Why?
|
| Diphosphonates | 1 | 2009 | 39 | 0.310 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 52 | 0.300 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 502 | 0.290 |
Why?
|
| Infant, Newborn | 16 | 2025 | 8308 | 0.280 |
Why?
|
| Infant | 15 | 2025 | 12681 | 0.280 |
Why?
|
| United States | 9 | 2024 | 10990 | 0.270 |
Why?
|
| Male | 29 | 2025 | 62031 | 0.270 |
Why?
|
| Career Choice | 2 | 2012 | 153 | 0.260 |
Why?
|
| Decision Making | 1 | 2012 | 671 | 0.260 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2009 | 161 | 0.260 |
Why?
|
| Pediatrics | 2 | 2013 | 1161 | 0.250 |
Why?
|
| Quality Improvement | 2 | 2023 | 653 | 0.250 |
Why?
|
| Neuropsychological Tests | 3 | 2024 | 912 | 0.250 |
Why?
|
| Retrospective Studies | 18 | 2025 | 16517 | 0.240 |
Why?
|
| Physicians | 1 | 2012 | 603 | 0.240 |
Why?
|
| Adult | 18 | 2025 | 29802 | 0.240 |
Why?
|
| Prevalence | 5 | 2022 | 2484 | 0.220 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 83 | 0.220 |
Why?
|
| Laparotomy | 1 | 2024 | 136 | 0.210 |
Why?
|
| Patient Care Team | 2 | 2025 | 550 | 0.210 |
Why?
|
| Folic Acid | 2 | 2022 | 295 | 0.200 |
Why?
|
| Ventriculostomy | 2 | 2025 | 36 | 0.200 |
Why?
|
| Chronic Disease | 4 | 2023 | 1204 | 0.200 |
Why?
|
| Decompression, Surgical | 2 | 2024 | 90 | 0.200 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2024 | 77 | 0.200 |
Why?
|
| Pandemics | 2 | 2021 | 1129 | 0.200 |
Why?
|
| Emigration and Immigration | 1 | 2023 | 81 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2022 | 98 | 0.190 |
Why?
|
| Disabled Persons | 1 | 2023 | 92 | 0.190 |
Why?
|
| Child Development | 1 | 2025 | 270 | 0.190 |
Why?
|
| Treatment Outcome | 12 | 2025 | 12380 | 0.190 |
Why?
|
| Urology | 1 | 2022 | 79 | 0.190 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 193 | 0.190 |
Why?
|
| Internship and Residency | 1 | 2012 | 1189 | 0.180 |
Why?
|
| Diseases in Twins | 1 | 2021 | 94 | 0.180 |
Why?
|
| Urinary Bladder | 2 | 2022 | 239 | 0.170 |
Why?
|
| Laser Coagulation | 1 | 2021 | 129 | 0.170 |
Why?
|
| Spina Bifida Cystica | 1 | 2020 | 35 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 185 | 0.170 |
Why?
|
| Neurosurgeons | 1 | 2020 | 12 | 0.170 |
Why?
|
| Neurogenic Bowel | 1 | 2020 | 5 | 0.170 |
Why?
|
| Congenital Abnormalities | 1 | 2002 | 259 | 0.160 |
Why?
|
| Gestational Age | 4 | 2025 | 1174 | 0.150 |
Why?
|
| Fetofetal Transfusion | 1 | 2021 | 194 | 0.150 |
Why?
|
| Ulcer | 1 | 2019 | 49 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 223 | 0.150 |
Why?
|
| Counseling | 1 | 2020 | 223 | 0.140 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 49 | 0.140 |
Why?
|
| Urination | 1 | 2017 | 24 | 0.140 |
Why?
|
| Comprehensive Health Care | 1 | 2017 | 18 | 0.140 |
Why?
|
| Cognition Disorders | 2 | 2020 | 550 | 0.140 |
Why?
|
| Prenatal Diagnosis | 4 | 2025 | 607 | 0.140 |
Why?
|
| Molecular Epidemiology | 1 | 2017 | 156 | 0.140 |
Why?
|
| Research | 1 | 2019 | 265 | 0.130 |
Why?
|
| Self Efficacy | 1 | 2017 | 201 | 0.130 |
Why?
|
| Personal Autonomy | 1 | 2017 | 202 | 0.130 |
Why?
|
| Disease Management | 1 | 2020 | 529 | 0.120 |
Why?
|
| Skin | 1 | 2019 | 527 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 375 | 0.120 |
Why?
|
| Endoscopy | 1 | 2017 | 282 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2019 | 550 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 446 | 0.100 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 628 | 0.100 |
Why?
|
| Organ Size | 2 | 2024 | 444 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 5204 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2012 | 396 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2013 | 286 | 0.080 |
Why?
|
| Language Development Disorders | 2 | 2009 | 175 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3078 | 0.080 |
Why?
|
| Fractures, Spontaneous | 1 | 2009 | 18 | 0.080 |
Why?
|
| Long-Term Care | 1 | 2009 | 66 | 0.080 |
Why?
|
| Matched-Pair Analysis | 1 | 2008 | 28 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 525 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 6645 | 0.070 |
Why?
|
| Body Height | 1 | 2009 | 220 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 974 | 0.070 |
Why?
|
| Health Status | 2 | 2012 | 385 | 0.070 |
Why?
|
| Bone Density | 1 | 2009 | 324 | 0.060 |
Why?
|
| Age of Onset | 1 | 2008 | 608 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3622 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2008 | 401 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2022 | 6175 | 0.060 |
Why?
|
| Qatar | 1 | 2025 | 2 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 635 | 0.060 |
Why?
|
| Fetal Therapies | 1 | 2025 | 80 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2009 | 3341 | 0.060 |
Why?
|
| Aged | 5 | 2022 | 19962 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1129 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1341 | 0.050 |
Why?
|
| Ampicillin Resistance | 1 | 2003 | 17 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 3457 | 0.050 |
Why?
|
| Sweden | 1 | 2023 | 35 | 0.050 |
Why?
|
| Argentina | 1 | 2023 | 53 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2023 | 51 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 235 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 57 | 0.050 |
Why?
|
| Middle Aged | 5 | 2022 | 27031 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 274 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 2002 | 77 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 109 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2023 | 109 | 0.050 |
Why?
|
| Incidence | 2 | 2021 | 3170 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 3716 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 2103 | 0.050 |
Why?
|
| Risk Factors | 3 | 2021 | 10375 | 0.050 |
Why?
|
| Internet | 1 | 2024 | 378 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Twins | 1 | 2021 | 69 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2002 | 162 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 20 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2021 | 45 | 0.050 |
Why?
|
| Encephalocele | 1 | 2021 | 50 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 241 | 0.040 |
Why?
|
| Thyroid Diseases | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cause of Death | 1 | 2023 | 477 | 0.040 |
Why?
|
| Developing Countries | 1 | 2002 | 274 | 0.040 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 180 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2003 | 304 | 0.040 |
Why?
|
| Suppositories | 1 | 2020 | 3 | 0.040 |
Why?
|
| Enema | 1 | 2020 | 37 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2020 | 43 | 0.040 |
Why?
|
| Fetus | 1 | 2023 | 590 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 769 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2002 | 399 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 119 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 221 | 0.040 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 171 | 0.040 |
Why?
|
| Urodynamics | 1 | 2017 | 40 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2017 | 39 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 240 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 513 | 0.040 |
Why?
|
| Africa | 1 | 2017 | 133 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 735 | 0.030 |
Why?
|
| Premature Birth | 1 | 2021 | 391 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 441 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 267 | 0.030 |
Why?
|
| Community Health Services | 1 | 2017 | 90 | 0.030 |
Why?
|
| Age Factors | 1 | 2023 | 2835 | 0.030 |
Why?
|
| Comorbidity | 1 | 2022 | 1542 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 362 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 678 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2020 | 390 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 176 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2002 | 740 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 290 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 611 | 0.030 |
Why?
|
| Tracheostomy | 1 | 2018 | 198 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 299 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 2194 | 0.030 |
Why?
|
| Accreditation | 1 | 2013 | 90 | 0.030 |
Why?
|
| Epilepsy | 1 | 2020 | 875 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 4874 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 240 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2002 | 2406 | 0.020 |
Why?
|
| Texas | 1 | 2019 | 3587 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1725 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2012 | 771 | 0.020 |
Why?
|
| Stanford-Binet Test | 1 | 2009 | 2 | 0.020 |
Why?
|
| Communication Disorders | 1 | 2009 | 8 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2009 | 42 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2009 | 98 | 0.020 |
Why?
|
| Head | 1 | 2009 | 104 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4742 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1969 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 1193 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6334 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3203 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1020 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2012 | 728 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2009 | 431 | 0.020 |
Why?
|
| Cefotaxime | 1 | 2003 | 36 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 1909 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 33 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2002 | 12 | 0.010 |
Why?
|
| Utah | 1 | 2002 | 46 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2003 | 70 | 0.010 |
Why?
|
| Gentamicins | 1 | 2003 | 94 | 0.010 |
Why?
|
| Meningitis | 1 | 2003 | 98 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 86 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 192 | 0.010 |
Why?
|
| Seasons | 1 | 2002 | 314 | 0.010 |
Why?
|
| Fever | 1 | 2003 | 299 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2933 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 361 | 0.010 |
Why?
|
| Gastroenteritis | 1 | 2003 | 349 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 800 | 0.010 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 236 | 0.010 |
Why?
|
| Bacteremia | 1 | 2003 | 401 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 771 | 0.010 |
Why?
|